SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 140 filers reported holding SUTRO BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,401,069 | -25.4% | 2,132,873 | 0.0% | 0.03% | -23.8% |
| Q2 2023 | $9,917,859 | +0.6% | 2,132,873 | 0.0% | 0.04% | -12.5% |
| Q1 2023 | $9,853,873 | -47.3% | 2,132,873 | -7.8% | 0.05% | -57.9% |
| Q4 2022 | $18,693,419 | +20.1% | 2,313,542 | -17.5% | 0.11% | +15.2% |
| Q3 2022 | $15,569,000 | +6.5% | 2,805,197 | 0.0% | 0.10% | +12.5% |
| Q2 2022 | $14,615,000 | -2.9% | 2,805,197 | +53.1% | 0.09% | +12.8% |
| Q1 2022 | $15,057,000 | -36.1% | 1,831,755 | +15.7% | 0.08% | -36.6% |
| Q4 2021 | $23,564,000 | -22.4% | 1,583,579 | -1.5% | 0.12% | -25.5% |
| Q3 2021 | $30,365,000 | +2.3% | 1,607,466 | +0.7% | 0.16% | -1.8% |
| Q2 2021 | $29,686,000 | -8.4% | 1,596,882 | +12.2% | 0.17% | -17.2% |
| Q1 2021 | $32,392,000 | +39.8% | 1,423,205 | +33.4% | 0.20% | +39.0% |
| Q4 2020 | $23,170,000 | – | 1,067,258 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |